UNICA IRIS Institutional Research Information System

CARDIA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 169.369
NA - Nord America 6.770
AS - Asia 3.228
SA - Sud America 450
AF - Africa 93
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 179.920
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 166.959
US - Stati Uniti d'America 6.631
SG - Singapore 1.194
CN - Cina 1.183
UA - Ucraina 546
SE - Svezia 493
DE - Germania 432
BR - Brasile 365
VN - Vietnam 272
FI - Finlandia 233
GB - Regno Unito 221
FR - Francia 189
IN - India 99
KR - Corea 87
NL - Olanda 84
HK - Hong Kong 83
CA - Canada 75
BD - Bangladesh 58
AT - Austria 33
RU - Federazione Russa 32
IQ - Iraq 31
PL - Polonia 29
MA - Marocco 28
PK - Pakistan 28
TR - Turchia 27
JP - Giappone 26
IR - Iran 24
MX - Messico 23
AR - Argentina 22
BE - Belgio 20
ES - Italia 20
PT - Portogallo 18
ID - Indonesia 17
CO - Colombia 16
VG - Isole Vergini Britanniche 16
ZA - Sudafrica 16
PH - Filippine 14
EC - Ecuador 13
IE - Irlanda 13
TN - Tunisia 12
EG - Egitto 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
AU - Australia 8
JM - Giamaica 8
KE - Kenya 8
KG - Kirghizistan 8
IL - Israele 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
TW - Taiwan 6
BO - Bolivia 5
CH - Svizzera 5
HU - Ungheria 5
LT - Lituania 5
PY - Paraguay 5
CR - Costa Rica 4
DK - Danimarca 4
GT - Guatemala 4
MU - Mauritius 4
AL - Albania 3
ET - Etiopia 3
IS - Islanda 3
JO - Giordania 3
MD - Moldavia 3
PA - Panama 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
LK - Sri Lanka 2
NI - Nicaragua 2
PS - Palestinian Territory 2
UY - Uruguay 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
LU - Lussemburgo 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 179.916
Salva come PNG Salva come JPEG
Città #
Cagliari 162.581
Uta 3.107
Singapore 672
Ashburn 579
Chandler 494
San Jose 473
Fairfield 429
Woodbridge 371
Dallas 346
Boardman 336
Nyköping 315
Jacksonville 300
Ann Arbor 282
Houston 236
Beijing 216
Dearborn 208
Wilmington 200
Seattle 173
Los Angeles 150
Helsinki 149
New York 144
Cambridge 134
Santa Clara 117
Hefei 100
Shanghai 99
Lauterbourg 95
Nanjing 93
Council Bluffs 88
Seoul 84
The Dalles 82
Milan 81
Ho Chi Minh City 73
Hong Kong 70
Boston 65
Hanoi 60
Rome 54
Buffalo 45
Guangzhou 44
Nanchang 38
Munich 37
Toronto 36
Shenyang 35
Redwood City 33
São Paulo 31
Orem 30
Vienna 29
Changsha 27
Chicago 26
Parma 25
San Diego 23
Tokyo 23
Casablanca 22
Dong Ket 22
Naples 22
Tianjin 22
Verona 21
Hebei 20
Florence 19
Jinan 19
Amsterdam 18
Brussels 18
Jiaxing 18
La Puente 18
Nürnberg 18
Redondo Beach 18
Frankfurt am Main 17
Brooklyn 16
Chennai 16
London 16
Road Town 16
Sassari 16
Denver 15
Montreal 15
Turin 15
Atlanta 14
Haiphong 14
Orange 14
Mountain View 13
Norwalk 13
Warsaw 13
Auburn Hills 12
Padova 12
Baghdad 11
Catania 11
Hangzhou 11
Johannesburg 11
Nuremberg 11
Stockholm 11
Turku 11
Washington 11
Bologna 10
Dublin 10
Kingston 10
Rende 10
Rio de Janeiro 10
Augusta 9
Bari 9
Istanbul 9
Kunming 9
Lodz 9
Totale 174.243
Salva come PNG Salva come JPEG
Nome #
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.614
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.606
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.325
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.932
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.896
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.782
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.533
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.502
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.492
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.474
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.354
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.293
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.285
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.265
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.226
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 3.021
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.978
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.826
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.804
null 2.749
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.623
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.621
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.542
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.466
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.420
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.389
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.353
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.318
New promising scaffolds for the inhibition of monoamine oxidase B 2.311
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.296
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.273
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.185
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.157
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.149
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.111
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.091
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.057
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.980
null 1.949
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 1.939
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.939
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.932
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.889
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.871
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.817
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.711
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.690
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.669
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.665
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.652
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.633
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.601
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.477
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.458
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.435
null 1.415
null 1.406
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.197
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.157
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.135
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.119
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 1.112
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 1.058
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 1.048
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.043
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 1.041
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 998
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 980
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 976
CoMFA studies of non-covalent monoamine oxidase inhibitors 946
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 944
null 943
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 930
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 917
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 914
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 912
Computational and experimental study of non-covalent monoamine oxidase inhibitors 888
Novel MAO-B selective inhibitors developed using computational methods 868
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 859
Topoisomerase I: synthesis of a new class of potential inhibitors 835
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 829
null 818
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 814
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 769
null 735
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 709
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 696
null 693
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 682
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 661
null 617
null 610
Synthesis of new arylidencycloalkylpyrazoles of biological interest 608
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 554
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 509
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 487
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 463
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 416
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 403
Production of liposomes by microfluidics: The impact of post-manufacturing dilution on drug encapsulation and lipid loss 341
Totale 178.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.320 0 0 0 0 0 0 0 0 0 0 0 1.320
2021/20227.147 991 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.892 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 1.345
2024/202522.055 3.608 4.952 5.648 2.362 1.250 1.438 1.603 154 255 209 239 337
2025/20267.719 476 292 774 630 487 536 1.112 716 636 1.148 495 417
Totale 180.160